Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport in Vulvodynia
NCT03598777Phase 2Terminated
- Sponsor
- Ipsen
- Start
- Jun 2018
- Primary completion
- Jan 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of abobotulinumtoxinA in vulvodynia, sponsored by Ipsen. Started Jun 2018; status: terminated.
02
Drugs
abobotulinumtoxinA
03
Conditions
vulvodynia
Beyond the preview
Go deeper on NCT03598777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03598777.